Atopic dermatitis (eczema) trials in United States

In United States 77 Also abroad 251

77 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Skin Microbial Ecology in Atopic Dermatitis
Where
Rochester
Age
13 years and over
People
240
Run by
University of Rochester
See details and how to joinNCT04170244
No phaseTaking people
Sodium in the Skin and Atopic Dermatitis
Where
San Francisco
Age
50 years and over
People
90
Run by
University of California, San Francisco
See details and how to joinNCT06998446
Phase 1Taking people
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
Where
Chicago, Cincinnati, Denver, Madison, New York, Rochester, San Diego
Age
6 years and over
People
86
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT06504160
No phaseTaking people
CorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness Registry
Where
Waltham
Age
10 years to 15 years
People
1,500
Run by
CorEvitas
See details and how to joinNCT06238765
Phase 2Taking people
Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Where
Bellaire, Fountain Valley, Fremont, Los Angeles, Sacramento, Webster
Age
18 years to 65 years
People
114 worldwide
Run by
Oneness Biotech Co., Ltd.
See details and how to joinNCT06397911
Phase 4Taking people
Molecular Signatures of Cutaneous Dupilumab Response
Where
San Francisco
Age
18 years and over
People
15
Run by
University of California, San Francisco
See details and how to joinNCT05858619
Phase 4Not yet taking people in United States
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Where
San Francisco
Age
18 years and over
People
10
Run by
University of California, San Francisco
See details and how to joinNCT07352566
No phaseTaking people
Mechanisms of Increased Disease Severity in AD Patients With the IL-4Ra R576 Polymorphism
Where
Boston
Age
6 years to 65 years
People
111
Run by
Boston Children's Hospital
See details and how to joinNCT04455906
Phase 1Taking people
A 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
Where
Arkansas City, Boardman, Bountiful, Fremont, Philadelphia, Plainfield
Age
18 years to 65 years
People
149 worldwide
Run by
Sitryx Therapeutics Ltd
See details and how to joinNCT07558668
Phase 4Taking people
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
Where
Chicago
Age
6 years to 17 years
People
40
Run by
Northwestern University
See details and how to joinNCT05042258
No phaseEnrolling by invitation
Investigation of Filaggrin Gene Mutations Among Latinx Patients With Atopic Dermatitis
Where
Philadelphia
People
300
Run by
University of Pennsylvania
See details and how to joinNCT06464133
No phaseTaking people
Registry for Systemic Eczema Treatments
Where
Baltimore
Age
1 year to 26 years
People
400
Run by
Johns Hopkins University
See details and how to joinNCT06136767
No phaseTaking people
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Where
Auburn, Auburn Hills, Birmingham, Bluffton, Boca Raton, Bountiful, Brighton, Caledonia, Castle Rock, Cedar Park, Chicago, Columbia, Coral Gables, Corona, Cutler Bay, Dallas, Dayton, East Syracuse, Edinburg, Fairfield, Fountain Valley, Fremont, Glenn Dale, Grandville, Grapevine, Gresham, Hollywood, Indianapolis, Jupiter, Las Vegas, Lee's Summit, Los Angeles, Miami, Milford, Morgantown, Mount Kisco, Newport Beach, New York, North Miami Beach, Oakland Park, Philadelphia, Phoenix, Portsmouth, Rockville, Santa Monica, St. Petersburg, Sugar Land, Tampa, Thousand Oaks, Troy, Tucson, Vienna, Waco, West Lafayette
Age
12 years and over
People
1,000 worldwide
Run by
Galderma R&D
See details and how to joinNCT06988605
Phase 4Not yet taking people in United States
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
Where
Boston
Age
6 years and over
People
100
Run by
Boston Children's Hospital
See details and how to joinNCT06397781
Phase 2Taking people
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Where
South San Francisco
Age
18 years and over
People
200 worldwide
Run by
Corvus Pharmaceuticals, Inc.
See details and how to joinNCT07441395 · EU 2025-524384-20-00
No phaseTaking people
Flourish: Exploring the Early Infant Gut Microbiome
Where
Austin
Age
0 months to 3 months
People
250
Run by
Seeding Inc
See details and how to joinNCT07333482
No phaseTaking people
Allergy and Immunology Natural History Study
Where
New York
Age
Up to 99 years
People
10,000
Run by
Columbia University
See details and how to joinNCT05584488
Phase 1Taking people
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
Where
Dallas, Fargo
Age
18 years and over
People
48 worldwide
Run by
LAPIX Therapeutics Inc.
See details and how to joinNCT06982352
No phaseTaking people
Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population
Where
Morrisville
Age
15 years to 50 years
People
958
Run by
Incyte Corporation
See details and how to joinNCT06259669
No phaseTaking people
An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis Exposed to Ruxolitinib Cream Versus Topical Corticosteroids During Pregnancy: A US Claims Database Analysis
Where
Morrisville
Age
14 years and over
People
5,621
Run by
Incyte Corporation
See details and how to joinNCT06627335
No phaseTaking people
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
Where
New York
Age
0 years and over
People
400
Run by
Pfizer
See details and how to joinNCT05721937
Phase 4Taking people
Ethnic Differences in Mechanisms of Action of Dupilumab
Where
Ann Arbor
Age
18 years and over
People
30
Run by
University of Michigan
See details and how to joinNCT05268107
Phase 1Taking people
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
Where
Camp Hill, North Little Rock, Philadelphia
Age
18 years and over
People
45
Run by
Brexogen Inc.
See details and how to joinNCT06055361
No phaseTaking people
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
Where
La Jolla
People
900
Run by
University of California, San Diego
See details and how to joinNCT05938478
Phase 2Taking people
A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab
Where
Ann Arbor, Sacramento
Age
18 years to 75 years
People
60
Run by
AbbVie
See details and how to joinNCT06524635